Advancing the Nation’s Bioeconomy
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States. The institute’s work will positively impact not only manufacturing but also healthcare and education & workforce development for the nation.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations. The mission of BioFabUSA is to bring together the fundamental tenets of good manufacturing processes and the science of regenerative medicine to create regenerative manufacturing and the trained and ready workforce necessary for that manufacturing.
ARMI BioIndustries is the full-service development, manufacturing and commercialization operation for the Advanced Regenerative Manufacturing Institute.
NextFab is the first Foundry for American Biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
As an ARMI | BioFabUSA member, your organization will benefit from the diverse experiences and capabilities of other members while we all seek to transform tissue engineering and regenerative medicine research into an industry that delivers tissues and organs to people in need.
It’s been nearly five years since Dean Kamen announced the launch of BioFabUSA, a program of the Advanced Regenerative Manufacturing Institute to jump-start the large-scale production of synthetic human tissue. Under the direction of Chief Technology Officer Tom Bollenbach, BioFabUSA has created a “tissue foundry” as a working prototype to manufacture cells, which increases the rate needed to produce them for early clinical trials.
“There are hurdles that need to be overcome with tissue and organs for human transplant, and sometimes the traditional connection between industry and academia can be slow going. ARMI | BioFabUSA can accelerate this.”
Associate Professor at Arizona State University